Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

N-{[(5S)-3-(3-fluoro-4-thiomorpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide

EU orphan designation number: EU/3/11/897   
Active ingredient: N-{[(5S)-3-(3-fluoro-4-thiomorpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide
Indication: Treatment of tuberculosis
Sponsor: RLM Consulting
Chemin du Cyclotron 6, B-1348 Louvain-la-Neuve, Belgique

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/09/2011 Centralised Orphan - Designation EMA/OD/029/11 (2011)6283 of 30/08/2011
08/10/2014 Centralised Orphan - Transfer of orphan designation EMA/OD/029/11/T/01 (2014)7397 of 06/10/2014